Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRF1 | P14222 | 15/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19686095 | 0.89 | MAPT (0.53) | PRF1MAPTLMNAGAAMAOA | |
| SCHEMBL19685756 | 0.88 | MAOA (0.47) | PRF1MAPTLMNAGAAMAOA | |
| SCHEMBL19686075 | 0.85 | PARP10 (0.44) | PRF1MAPTLMNAMAOAMAOB | |
| SCHEMBL19685757 | 0.82 | MAOA (0.42) | PRF1MAPTLMNAMAOAMAOB | |
| SCHEMBL19685754 | 0.80 | MAOA (0.52) | MAPTLMNAGAAMAOAMAOB | |
| SCHEMBL16573996 | 0.78 | PRF1 (0.61) | PRF1MAPTLMNAGAAMAOA | |
| SCHEMBL10110906 | 0.77 | TDP2 (0.47) | MAPTLMNAALDH1A1 | |
| SCHEMBL19685808 | 0.77 | TYRO3 (0.40) | MAPTLMNAMAOAMAOBALDH1A1 | |
| SCHEMBL19685911 | 0.75 | HSD17B1 (0.61) | MAPTMAOAMAOBALDH1A1 | |
| SCHEMBL19966686 | 0.74 | PRF1 (0.61) | PRF1MAPTLMNAGAAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | CYC1, CCNA1, CYCS | PRF1 840/4885MAPT 4713/4885LMNA 3026/4885 |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | PRF1 840/4885MAPT 4713/4885LMNA 3026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.